J Korean Med Assoc Search


J Korean Med Assoc > Volume 47(4); 2004 > Article
Lee: Treatment of Obese Binge Eater


It is now widely recognized that there is a subgroup of obese individuals with a significantly disordered eating behavior characterized by binge eating and psychosocial impairment. Many therapeutic approaches for the treatment of obese binge eaters including cognitive-behavioral therapy, treatment of obesity, nutritional counseling, psychoeducation, psychotherapy, motivation enhancement therapy, and medication have their own benefits. Treatment programs for obesity and eating disorders (binge eater, bulimia) have tended to adopt very different approaches to the eating behavior (dieting vs cessation of dieting) and body image (weight loss vs accepting one's current weight). Despite these differences, eating disorders, obesity, and unhealthy weight loss practices have a number of shared personal, socioenvironmental, and behavioral problems. It is important to integrate the treatment approaches to the spectrum of problems related to eating and weight (eating disorders, obesity, and unhealthy weight loss practices).


1. Lori MI, Dianne NS. Integrating of prevention of eating disorder and obesity: feasible or futile? Preventive Medicine 2002;34:299-309.

2. Stunkard AJ. Eating patters and obesity. Psychiatr Q 1959;33:284-292.

3. Spitzer RL, Devlin MJ, Walsh BT, Hasin D, Wing RR, Nonas C, et al. Binge eating disorder: A multisite field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203.

4. de Zwaan M, Mitchell JE, Raymond NC, Spitzer RL. Binge eating disorder: Clinical features and treatment of a new diagnosis. Harv Rev Psychiatry 1994;1:310-325.

5. Yanovski SZ, Spitzer RL. Binge eating disorder is associated with psychiatric comorbidity in the obese. Am J Psychiatry 1993;150:1472-1479.

6. Marcus MD. In: Brownell KD, Fairburn CG, editor. Binge eating and obesity. eating disorders and obesity 1995;New York: The Guilford Press. 441-444.

7. Garner DM, Olmsted MP, Davis R, Rockert W, Goldbloom D, Eagle M. The association between bulimic symptoms and reported psychopathology. Int J Eat Disord 1990;9:1-15.

8. Ranson KM, Kaye WH, Weltzin TE, Rao R, Matsunaga H. Obsessive-compulsive disorder symptoms before and after recovery from bulimia nervosa. Am J Psychiatry 1999;156:1703-1708.

9. Anderson AE, Bowers W, Watson T. A slimming program for ED NOS: Reconceptualizing a confusing residual diagnosis category. Psychiatr Clin North Am (in press).

10. Robin FA, Agras WS. Overcoming eating disorders: A cognitive-behavioral treatment for bulimia nervosa and binge-eating disorder 1998;1-20.

11. Wiiliam RM, Stephen R. Motivational interviewing: Preparing people for change 2002;2nd ed. New York: The Guilford Press. 201-206.

12. Agras WS, Scott JC, Katherine AH, James EM, Terence WG, Helena CK. Outcome predictors for the cognitie behavioral treatment of bulimia nervosa: data from a multisite study. Am J Psychiatry 2000;157:1302-1308.

13. Fairburn CG, Kirk J, O'Connor M. A comparison of two psychological treatment for bulimia nervosa. Behav Res Ther 1986;24:629-643.

14. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-147.

15. Susan LM, Leah SC, Eric BN, Kathleen AL, Cesar AS, James IH, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000;157:1004-1006.

16. James IH, Susan LM, Nancy CR, Scott C, Paul EK, Jeffrey MJ, et al. Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled double-blind trial. Am J Psychiatry 1998;155:1756-1762.

17. Neumeister A, Winkler A, Wöber-Bingöl C. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder. Am J Psychiatry 1999;156:797.

18. Steven JR, Katherin AH, Neena PS, Stephanie CK, Jalia SL. A placebo-controlled study of fluoxetine in controlled treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 2002;159:96-102.


Browse all articles >

Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next